Journal article
Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.
- Abstract:
-
Purpose
Expand abstract
Our aim was to determine the role of end-of-induction (EOI) minimal residual disease (MRD) assessment in the identification and stratification of induction failure in patients with pediatric acute lymphoblastic leukemia (ALL) and to identify genetic abnormalities that drive disease in these patients.
Patients and Methods
Analysis included 3,113 patients who were treated in the Medical Research Council UKALL2003 multicenter randomized trial (NCT0...
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 1.1MB)
-
- Publisher copy:
- 10.1200/JCO.2016.69.6278
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Bloodwise
More from this funder
Bibliographic Details
- Publisher:
- American Society of Clinical Oncology Publisher's website
- Journal:
- Journal of Clinical Oncology Journal website
- Volume:
- 35
- Issue:
- 6
- Pages:
- 660-667
- Publication date:
- 2017-01-03
- Acceptance date:
- 2016-10-25
- DOI:
- EISSN:
-
1527-7755
- ISSN:
-
0732-183X
- Source identifiers:
-
671005
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:671005
- UUID:
-
uuid:3b3b91b3-e851-4ddb-badf-8b8379bb6a5e
- Local pid:
- pubs:671005
- Deposit date:
- 2017-02-09
Terms of use
- Copyright holder:
- American Society of Clinical Oncology
- Copyright date:
- 2017
- Notes:
- © 2017 American Society of Clinical Oncology. All rights reserved. This is the publisher's version of the article. It is also available online from the American Society of Clinical Oncology at: [10.1200/JCO.2016.69.6278]
If you are the owner of this record, you can report an update to it here: Report update to this record